Microchip Technology announces the DSA504RT, a radiation-tolerant, six-output programmable clock generator designed for spacecraft timing systems. This new device aims to simplify timing architecture, reduce component count, and improve reliability in aerospace and defense applications. It offers high precision, low-power consumption, and integrated functionality, helping to lower costs and accelerate design processes for customers working with Microchip's space-qualified ecosystem.

Lightbridge Corporation announced the successful removal of the first batch of its fuel material samples from Idaho National Laboratory’s Advanced Test Reactor. These samples will undergo post-irradiation examination to collect crucial data on their properties under high-burnup irradiation conditions, supporting Lightbridge Fuel™'s commercial deployment and regulatory licensing efforts. The testing uses the Fission Accelerated Steady-state Testing (FAST) method, developed at INL, which allows for accelerated irradiation to achieve high burnup faster than conventional methods.

Micron Technology's stronger-than-expected earnings and increased capital expenditure guidance have fueled a global tech stock rally, alleviating investor fears about an AI bubble. JPMorgan analysts project continued growth for the S&P 500, driven by profitable AI hyperscaler investments, despite warnings of potential "flash-crashes" in speculative tech. The article also notes a shift in market performance, with broader S&P 500 stocks outperforming the "Magnificent 7" tech giants recently.

SEALSQ and WISeKey have formed Quantisimo Corp., a special purpose vehicle, and entered a non-binding Letter of Intent with GigCapital8 Corp. for a proposed business combination. This transaction aims to create a Nasdaq-listed strategic quantum technology platform with an initial enterprise value of $575 million, which the parties intend to increase to $2 billion through additional acquisitions of quantum companies. The initiative seeks to provide investors with direct exposure to the rapidly emerging quantum economy, leveraging WISeKey’s cybersecurity expertise and SEALSQ’s semiconductor and post-quantum technologies, aligning with recent U.S. government support for quantum innovation.

Taysha Gene Therapies announced the pricing of a public offering of 32,500,001 shares of common stock at $6.00 per share and pre-funded warrants for 833,333 shares at $5.999 per warrant. The company expects to raise approximately $200.0 million from this offering, which is anticipated to close around June 26, 2026. This capital raise will support the clinical-stage biotechnology company's work on AAV-based gene therapies for severe monogenic diseases of the central nervous system.

Kaltura receives highest possible score in audience engagement and interaction criterion. evaluation recognizes its vision for agentic, personalized event experiences. Kaltura receives highest possible score in audience engagement and interaction criterion.